Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
NeoGenomics, Inc.'s (NEO) CEO Doug VanOort on Q3 2020 Results - Earnings Call Transcript
03:31pm, Tuesday, 27'th Oct 2020
NeoGenomics, Inc.'s (NEO) CEO Doug VanOort on Q3 2020 Results - Earnings Call Transcript
Global Liquid Biopsy Market Analysis and Forecast, 2020-2030 & Implications of COVID-19 Pandemic on the Market - ResearchAndMarkets.com
12:00am, Wednesday, 14'th Oct 2020
The
NeoGenomics (NEO) Investor Presentation - Slideshow
05:09pm, Wednesday, 02'nd Sep 2020
The following slide deck was published by NeoGenomics, Inc. in conjunction with this event..
NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $128.91 Million
01:28am, Tuesday, 11'th Aug 2020
Equities analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will post $128.91 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided e
NeoGenomics (NASDAQ:NEO) Stock Rating Lowered by Zacks Investment Research
07:58am, Sunday, 09'th Aug 2020
NeoGenomics (NASDAQ:NEO) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “NeoGe
LD Micro: Announces Preliminary List of Presenters for the LD-500
05:43pm, Thursday, 06'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
NeoGenomics Slumps in Q2 but Readies for Second-Half Rebound
03:11pm, Wednesday, 05'th Aug 2020
The oncology reference lab never stopped investing in near- and long-term opportunities. It expects that to pay off -- and soon.
NeoGenomics (NASDAQ:NEO) Price Target Raised to $45.00 at SVB Leerink
05:42am, Sunday, 02'nd Aug 2020
NeoGenomics (NASDAQ:NEO) had its price target raised by SVB Leerink from $35.00 to $45.00 in a research note released on Wednesday, The Fly reports. They currently have an outperform rating on the med
NeoGenomics, Inc. (NASDAQ:NEO) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
02:52pm, Thursday, 30'th Jul 2020
It's been a good week for NeoGenomics, Inc. (NASDAQ:NEO) shareholders, because the company has just released its...
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
Neogenomics Inc (NEO) Q2 2020 Earnings Call Transcript
05:30pm, Tuesday, 28'th Jul 2020
Joining me from our Fort Myers headquarters, with social distancing precautions in place, are Kathryn McKenzie, our Chief Financial Officer; Rob Shovlin, President of our Clinical Division; and Bill B
Recap: NeoGenomics Q2 Earnings
02:34pm, Tuesday, 28'th Jul 2020
Shares of NeoGenomics (NASDAQ:NEO) rose 1% after the company reported Q2 results.Quarterly Results Earnings per share fell 157.14% over the past year to ($0.04), which beat the estimate of ($0.10).Rev
NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q2 2020 Results - Earnings Call Transcript
02:23pm, Tuesday, 28'th Jul 2020
NeoGenomics, Inc. (NASDAQ:NEO) Q2 2020 Earnings Conference Call July 28, 2020 08:30 AM ET Company Participants Doug VanOort - Chief Executive Officer Kathryn McKenzie - Chief Financial Officer Rob Sho
NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates
01:55pm, Tuesday, 28'th Jul 2020
NeoGenomics (NEO) delivered earnings and revenue surprises of 55.56% and 1.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
What Can We Conclude About NeoGenomics' (NASDAQ:NEO) CEO Pay?
12:59pm, Tuesday, 28'th Jul 2020
This article will reflect on the compensation paid to Doug VanOort who has served as CEO of NeoGenomics, Inc...
